230 related articles for article (PubMed ID: 1443562)
1. Noncolorimetric measurement of cell activity in three-dimensional histoculture using the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide: the pixel image analysis of formazan crystals.
Colangelo D; Guo HY; Connors KM; Silvestro L; Hoffman RM
Anal Biochem; 1992 Aug; 205(1):8-13. PubMed ID: 1443562
[TBL] [Abstract][Full Text] [Related]
2. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
Plumb JA; Milroy R; Kaye SB
Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
[TBL] [Abstract][Full Text] [Related]
3. Correlation of drug response in human tumors histocultured in vitro with an image-analysis MTT end point and in vivo xenografted in nude mice.
Colangelo D; Guo HY; Connors KM; Kubota T; Silvestro L; Hoffman RM
Anticancer Res; 1992; 12(5):1373-6. PubMed ID: 1444193
[TBL] [Abstract][Full Text] [Related]
4. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
[TBL] [Abstract][Full Text] [Related]
5. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
Vistica DT; Skehan P; Scudiero D; Monks A; Pittman A; Boyd MR
Cancer Res; 1991 May; 51(10):2515-20. PubMed ID: 2021931
[TBL] [Abstract][Full Text] [Related]
6. Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
Wang H; Wang F; Tao X; Cheng H
Anal Biochem; 2012 Feb; 421(1):324-6. PubMed ID: 22100715
[TBL] [Abstract][Full Text] [Related]
7. Backscattered light confocal imaging of intracellular MTT-formazan crystals.
Bernas T; Dobrucki JW
Microsc Res Tech; 2004 Jun; 64(2):126-34. PubMed ID: 15352083
[TBL] [Abstract][Full Text] [Related]
8. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
Cory AH; Owen TC; Barltrop JA; Cory JG
Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
Liu Y; Schubert D
J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
[TBL] [Abstract][Full Text] [Related]
10. Screen anticancer drug in vitro using resonance light scattering technique.
Chen Z; Liu G; Chen M; Xu B; Peng Y; Chen M; Wu M
Talanta; 2009 Feb; 77(4):1365-9. PubMed ID: 19084650
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
Pieters R; Huismans DR; Leyva A; Veerman AJ
Cancer Lett; 1988 Aug; 41(3):323-32. PubMed ID: 3165705
[TBL] [Abstract][Full Text] [Related]
12. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
Abe K; Saito H
Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
[TBL] [Abstract][Full Text] [Related]
13. Current methodology of MTT assay in bacteria - A review.
Grela E; Kozłowska J; Grabowiecka A
Acta Histochem; 2018 May; 120(4):303-311. PubMed ID: 29606555
[TBL] [Abstract][Full Text] [Related]
14. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC.
Bernas T; Dobrucki JW
Arch Biochem Biophys; 2000 Aug; 380(1):108-16. PubMed ID: 10900139
[TBL] [Abstract][Full Text] [Related]
15. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.
Twentyman PR; Luscombe M
Br J Cancer; 1987 Sep; 56(3):279-85. PubMed ID: 3663476
[TBL] [Abstract][Full Text] [Related]
16. Modification of the MTT method for the study of bilirubin cytotoxicity.
Ngai KC; Yeung CY; Karlberg J
Acta Paediatr Jpn; 1998 Aug; 40(4):313-7. PubMed ID: 9745771
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C.
Chakrabarti R; Kundu S; Kumar S; Chakrabarti R
J Cell Biochem; 2000 Sep; 80(1):133-8. PubMed ID: 11029760
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity antitumor drug sensitivity testing.
Kondo T; Wada K; Kawashima M; Sato Y; Yamauchi M
Oncology; 1994; 51(6):535-9. PubMed ID: 7970499
[TBL] [Abstract][Full Text] [Related]
20. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.
Abe K; Matsuki N
Neurosci Res; 2000 Dec; 38(4):325-9. PubMed ID: 11164558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]